Stock Market News

1 day IBD 50’s Hims & Hers Tumbles After FDA Pulls Lilly’s Weight-Loss Drug From Shortage List Investor's Business Daily

Hims stock skidded Thursday after the FDA determined Eli Lilly’s tirzepatide — which sells as a weight-loss drug — is no longer in shortage.
The post IBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage Lis…

Eli Lilly (LLY)

4 hours Eli Lilly’s Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive? Investor's Business Daily

8 hours Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture YouTube

8 hours Nvidia, Eli Lilly lead Friday’s market cap stock movers Investing.com

9 hours There’s a New Obesity King The Wall Street Journal

9 hours Eli Lilly: Improved Competitive Position In Obesity Market, But Strong Execution Is A Must Now Seeking Alpha

12 hours LLY Stock Up as FDA Removes Mounjaro, Zepbound From Shortage List Zacks

14 hours FedEx, Eli Lilly, Occidental rise premarket; Nike, Novo Nordisk fall Investing.com

14 hours Novo Nordisk’s new weight-loss drug works better, but not as well as expected MarketWatch

1 day Eli Lilly dips despite FDA confirming shortage of GLP-1 tirzepatide is over Investing.com

2 days FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage CNBC

2 days Zealand Pharma And Eli Lilly: Strategic Focus On Weight Management And Future Outlook Seeking Alpha

3 days Eli Lilly’s Alzheimer’s treatment approved in China Investing.com

3 days Eli Lilly Alzheimer’s drug donanemab approved in China Investing.com

3 days Eli Lilly (LLY) Stock Moves -0.05%: What You Should Know Zacks

3 days NVS vs. LLY: Which Stock Should Value Investors Buy Now? Zacks

4 days 15 Billion Reasons to Love Eli Lilly Stock Right Now Yahoo Finance

4 days Eli Lilly: A Rare Buying Opportunity Seeking Alpha

5 days Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf? Investor's Business Daily

5 days EMA Panel Endorses Lilly’s Omvoh for Expanded Use in Crohn’s Disease Zacks

1 week Eli Lilly’s Manjaro gains on Novo Nordisk’s Wegovy in UK Investing.com

1 week Eli Lilly Reports Positive Data From Late-Stage Breast Cancer Study Zacks

1 week Eli Lilly Stock Could Have a Huge Growth Catalyst in Early 2025 Yahoo Finance

1 week Eli Lilly (LLY) Stock Slides as Market Rises: Facts to Know Before You Trade Zacks

1 week Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly CNBC

1 week Eli Lilly to test obesity drugs to treat addiction in 2025, CEO says #shorts #weightloss #zepbound YouTube

1 week Eli Lilly to test obesity drugs for smoking, alcohol abuse – Bloomberg Investing.com

2 weeks Oracle, AutoZone and Alaska Air fell premarket; Eli Lilly rose Investing.com

2 weeks Lilly Announces New $15B Stock Buyback Plan, Ups Dividend by 15% Zacks

2 weeks The Zacks Analyst Blog Highlights Eli Lilly, AbbVie, Gilead Sciences, Air T and Fossil Group Zacks

2 weeks Eli Lilly announces $15 billion buyback, dividend hike Investing.com

2 weeks Top Stock Reports for Eli Lilly, AbbVie & Gilead Sciences Zacks

2 weeks Netflix, Eli Lilly among Monday’s market cap stock movers Investing.com

2 weeks Eli Lilly Stock Just Got Even Sweeter. Here’s Why It’s Worth Buying Now Yahoo Finance

2 weeks The Zacks Analyst Blog Eli Lilly, Novo Nordisk’s Amgen and Viking Therapeutics Zacks

2 weeks Eli Lilly to Invest $3B in Wisconsin Plant to Meet Obesity Drug Demand Zacks

2 weeks Pharma Stock Roundup: LLY’s Zepbound Success, FDA Updates for MRK, JNJ Zacks

2 weeks How to Play LLY Stock as Zepbound Beats NVO’s Wegovy in Obesity Study Zacks

2 weeks Eli Lilly Chief Scientific Officer explains Zepbound’s weight loss advantage YouTube

2 weeks Prescription fills for weight loss drugs Zepbound, Wegovy more than doubled in 2024, GoodRx says CNBC

2 weeks The Weight-Loss Battle That Could Rattle Eli Lilly’s $100 Billion Market Investor's Business Daily

2 weeks LLY’s Zepbound Outshines NVO’s Wegovy in Head-to-Head Obesity Study Zacks

2 weeks Eli Lilly Chief Says He Will Fight for the FDA, Challenging RFK Jr.’s Stance The New York Times

2 weeks Stocks making the biggest moves midday: JetBlue, Eli Lilly, Pure Storage, Salesforce and more CNBC

2 weeks Eli Lilly says ‘Zepbound superior to Wegovy in head-to-head trial Investing.com

2 weeks Eli Lilly says Zepbound’s weight-loss results beat those of rival Wegovy MarketWatch

2 weeks Battle Of The Weight-Loss Behemoths: Eli Lilly Whomps Novo Nordisk Investor's Business Daily

2 weeks Eli Lilly stock higher following surprise weight loss treatment data TheStreet

2 weeks Eli Lilly Just Got a Bundle of Good News: Time to Buy? Yahoo Finance

2 weeks Eli Lilly’s Zepbound causes greater weight loss than Novo Nordisk’s Wegovy in head-to-head trial CNBC

2 weeks Lightning Round: I prefer Eli Lilly over Regeneron YouTube

The Stock Market News

TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.